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Abstract
Members of the protein kinase C (PKC) family of serine/threonine kinases are thought to play critical roles in the
regulation of cellular differentiation and proliferation in many cell types. An additional member of the PKC family was
identified through human expressed sequence tag (EST) database search and its full length cDNA was isolated. Sequence
analysis revealed that the predicted translation product was composed of 890 amino acid residues and that the protein has
77.3% similarity to human PKC mu (PKCW) and 77.4% similarity to mouse PKD (the mouse homolog of PKCW). We
designated the new member as protein kinase C nu (PKCX). The PKCX messenger RNA was ubiquitously expressed in
various tissues when analyzed by Northern blots and reverse transcriptase-coupled polymerase chain reaction (PCR)
analyses. The chromosomal location of the gene was determined between markers WI-9798 and D2S177 on chromosome
2p21 region by PCR-based methods with both a human/rodent monochromosomal hybrid cell panel and a radiation hybrid
mapping panel. ß 1999 Elsevier Science B.V. All rights reserved.
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Protein kinase C (PKC) enzymes de¢ne a family of
serine/threonine kinases which should contribute to
the regulation of cellular di¡erentiation and prolifer-
ation in various types of cells [1]. They are typically
activated by the second messenger diacylglycerol and
participate in cellular responses to various agonists
like hormones, neurotransmitters, and growth factors
[1^4].
Molecular cloning of various PKC isoforms has
established that PKC is a multigene family [5]. To
date, ten members have been identi¢ed, which can be
grouped in three classes according to their primary
structure and in vitro activation requirements [1,3].
The ¢rst group, the conventional PKCs (PKCK, L1,
L2, and Q), require Ca2 to be activated in the pres-
ence of phosphatidylserine. The second group, the
novel PKCs (PKCN, O, R, a), are Ca2-independent.
The third group, the atypical PKCs (PKCj and V)
are Ca2-independent and are not stimulated by di-
acylglycerol or the tumor promoter 12-O-tetradeca-
noyl phorbol-13-ester. All PKC isozymes share a
conserved catalytic kinase domain in the carboxy
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terminal region and an amino terminal regulatory
site (C1). Common features of the C1 domain are a
conserved pseudosubstrate site and two adjacent
amino terminal cysteine cluster that are responsible
for phorbol ester binding [1,3].
An additional lone isoform, PKCW, which is also
referred to as PKD in mouse, has been described
[6,7]. Lack of the typical pseudosubstrate site as
well as the presence of two unique amino-terminal
hydrophobic domains together with its unusually
large molecular size are characteristic features of
this PKC isozyme. Furthermore, the presence of a
pleckstrin homology (PH) domain in the regulator
region [8] is an additional characteristic feature.
From the functional analysis of the PKD, diacylgly-
cerol, phorbol ester, and L-K-phosphatidyl-D-myo-in-
ositol-4,5-bisphosphate were found to promote
PKCW/PKD kinase activity [8,9].
Database search against the public EST division
(GenBank release, April 1997) using the tBLASTN
program to compare with the conserved serine/threo-
nine kinase domain reported several ESTs showing
the highest similarity to PKCW/PKD as follows:
GenBank/EMBL accession numbers AA379132,
AA483305, N28764 and N46176. Utilizing the con-
sensus sequence of these ESTs, the initial fragment of
the cDNA was ampli¢ed from an 8-week human
fetus cDNA library using primers, 5P-GAAAACA-
TAGAAAGACTGGGAGGGATGTGG-3P (corre-
sponds to nt 2333 to 2362) and 5P-AGACATA-
CAACTCAGCACTTAGACCAGCAG-3P (corre-
sponds to nt 4017 to 3988). To obtain a full-length
cDNA of the new PKC member, 5P- and 3P-rapid
ampli¢cation of cDNA end (RACE) were performed.
For 5P-RACE, nested primers, 5P-ATGCAGATT-
CCTCAAAGCAACAAGTATCTG-3P (corresponds
to nt 2628 to 2599) and 5P-TGACTTTCTTG-
TTTTGTGGGGAATCTCATC-3P (corresponds to
nt 2411 to 2382) were used with Marathon cDNA
ampli¢cation kit (Clonetech, USA). The second
5P-RACE experiments were performed using nested
primers, 5P-ATTATGAGAGCTGTCCCCATTGT-
TCTCACC-3P (corresponds to nt 2076 to 2047)
and 5P-TGCTGCTCTTCCTCTTTGTGTGCTTGA-
TGG-3P (corresponds to nt 1801 to 1772), and the
third 5P-RACE experiments were performed using
nested primers, 5P-TCACCACAGTAATCACAGA-
AAGTAGGAGCT-3P (corresponds to nt 1073 to
1044) and 5P-TAGAGAGTATGTGGACGAATC-
TGGAAGT-3P (corresponds to nt 1028 to 1001).
To mask possible arti¢cial mutation occurring in
the PCR process, multiple 5P-RACE products were
cloned and sequenced by the dideoxy chain-termina-
tion method with a 377 DNA sequencer (Applied
Biosystems, USA) according to the supplier’s instruc-
tions. The resultant consensus sequence was em-
ployed as the correct cDNA sequence.
The determined nucleotide sequence and deduced
amino acid sequence are shown in Fig. 1. The cDNA
of 4017 bp contains an open reading frame of 2670
bp with a 5P-untranslated region of 555 bp, and a
3P-noncoding region of 792 bp. The open reading
frame encodes a putative protein of 890 amino acid
residues having a molecular mass of 100.5 kDa (Fig.
1). The nucleotide sequence data reported here will
appear in the DDBJ, EMBL, and GenBank nucleo-
tide sequence databases under accession number
AB015982.
A homology search of the cDNA clone revealed
that it best matched with human PKCW (accession
number X75756, 69.4% identity and 77.3% similar-
ity) and mouse PKD (accession number Z34524,
69.1% identity and 77.4% similarity). Thus, the iso-
lated cDNA represents a new member of PKC fam-
ily, which composes a fourth PKC subgroup with
PKCW/PKD. This novel PKC and its gene symbol
were designated as PKC nu (PKCX) and PRKCN,
respectively, according to the proposal by the Hu-
man Gene Nomenclature Committee. Comparison
of the predicted amino acid sequence of PKCX with
PKCW and PKD sequences revealed that they com-
pose a fourth PKC subgroup (Fig. 2). By hydropathy
analysis, PKCW appeared to harbor an NH2-terminal
hydrophobic sequence (Pro-35 to Ile-55), but PKCX
contained no putative transmembranous portion.
The cysteine-rich motif, His-X12-Cys-X2-Cys-X10ÿ14-
Cys-X2-Cys-X4-His-X2-Cys-X7-Cys, which com-
plexes with the heavy metal ions zinc and cadmium
and is responsible for phorbol ester binding [2], is
fully conserved among the three enzymes (Fig. 1).
The catalytic domain contains all conserved amino
acid motifs considered to be functionally critical for
the enzymatic activity of protein kinases [10]. And
the residues of similar structure in serine/threonine
protein kinase catalytic domain are conserved in
PKCX except Asn-689 (aa 576^832). The PKCX con-
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Fig. 1. Nucleotide and deduced amino acid sequences of PKCX. The amino acid sequence is shown below the nucleotide sequence. As-
terisks indicate in-frame stop codons. The cysteine-rich domains are underlined and the PH domain is double-underlined.
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Fig. 1 (continued).
BBAMCR 10404 22-4-99
A. Hayashi et al. / Biochimica et Biophysica Acta 1450 (1999) 99^106102
tains a PH domain (aa 417^542) inserted between the
cysteine-rich domain and catalytic domain presented
in carboxyl terminus. The PH domain was initially
identi¢ed as a homologous region of approximately
120 amino acids, that is duplicated in pleckstrin, the
major substrate of protein kinase C in platelets
[11,12]. It was subsequently found that this domain
is present in large variety of proteins involved in
cellular signaling or cytoskeletal functions [13,14].
It has been suggested that PH domains mediate in-
termolecular and/or intramolecular interactions,but
their function and binding partners remain unclear.
Interestingly, PDGF stimulates PKD through the
activation of PLCQ and other PKC [15] and the
PKD PH domain plays a negative role in the regu-
lation of enzyme activity [16]. Conservation of PH
domain between PKCX and PKCW/PKD as well as
the overall homology suggests that they may share a
common interacting factor(s) and be regulated in a
similar fashion.
Tissue expression of PCKX was investigated by
Northern blot analysis. A single 6.2-kb transcript
was detected in varying degrees in all adults tissues
examined (Fig. 3). We also performed reverse tran-
scription-coupled PCR (RT^PCR) in 12 human tis-
sues with the primer set, 5P-GAAAACATAGAAA-
GACTGGGAGGGATGTGG-3P (corresponds to nt
2333 to 2362) and 5P-ATGCAGATTCCTCAAAG-
CAACAAGTATCTG-3P (corresponds to nt 2628 to
2599). The RT^PCR were carried out as described
previously [17^20]. Templates of the human tissue
poly(A) RNAs were purchased from Clontech. A
single 300 bp ampli¢ed product was detected in all
tissues at the same level (data not shown). Consider-
ing its ubiquitous expression in a wide variety of
human tissues, PKCX seems to be involved in a basic
housekeeping function in cells.
PCR-based chromosome mapping was carried out
basically following our previous papers [17^20]. The
human^rodent monochromosomal somatic cell hy-
brid panel (Mapping panel #2) and the radiation
hybrid panel (Genebridge 4) were purchased from
the National Institute of General Medicine Service,
Coriell Cell Repositories and Research Genetics,
USA, respectively. Primers used for PCR ampli¢ca-
tion were 5P-AAGTGATGATGCTGCCTGGGA-
AATACATGC-3P (corresponds to nt 3122 to 3152)
and 5P-AGACATACAACTCAGCACTTAGACCA-
GCAG-3P (corresponds to nt 4017 to 3988). An ap-
parent single ampli¢ed product with an expected size
of 888 bp was ampli¢ed only in the lane of the hy-
brid containing human chromosome 2 (data not
shown). The same signal was also detected from con-
trol human genomic DNA and cDNA. We deter-
mined the further subchromosomal location of the
gene by the radiation hybrid mapping method.
PCR analysis of the radiation hybrid panel was
performed with the same primers used in the above
assay. The radiation hybrid data were statistically
processed and analyzed by the RHMAPPER soft-
ware package (http://carbon.wi.mit.edu:8000/cgi-bin/
contig/rhmapper.pl). The data vector for PKCX gene
was 1000010000 0111100010 1101001011 0000100000
0200211000 0000010112 0000101011 1100110001
1101010100 001 and the consequent report indicated
the gene was mapped between markers WI-9798 and
D2S177, both of which have been cytogenetically
mapped to 2p21 region (Fig. 4). The position of
the gene is 5.76cR proximal from WI-9798
(lods 3.0). The position is 22.39 cR distal from the
Fig. 1 (continued).
BBAMCR 10404 22-4-99
A. Hayashi et al. / Biochimica et Biophysica Acta 1450 (1999) 99^106 103
Fig. 2. Amino acid sequence alignment of the PKCX with PKCW (accession number X75756) and PKD (accession number Z34524)
proteins. The amino acid sequences of PKCX, PKCW, and PKD were analyzed and aligned by GCG software. The predicted amino
acids are represented in one-letter designation. The most identical amino acids at each position are black-boxed and similar ones are
shadowed.
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upstream intermediator, PKCO [21], the location of
which has been determined by RH mapping method
also in our hands (Seki et al., unpublished data).
Recently, genomic ampli¢cation was observed on hu-
man chromosome 2p21 region in thyroid cancer by
use of the comparative genome hybridization (CGH)
method [22]. The sequence analysis of a BAC clone
from the ampli¢ed genomic region revealed that the
BAC contained a fragment of PKCO [22], suggesting
that PKCO may play a role in thyroid cancer devel-
opment. Fig. 4 shows a schematic representation of
chromosomal positions of the PKCX and PKCO
genes relative to other genetic markers on the frame-
work of radiation hybrid mapping. Our precise chro-
mosomal positioning data of such genes would con-
tribute toward on-going positional candidate
approaches for the disease genes linked to this ge-
nomic locus.
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